Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction

Biomaterials

Volumn 33, Issue 10, 2012, Pages 2872-2879

  Cheng, Ke ^a   Shen, Deliang ^a,b   Smith, Jeremy ^a   Galang, Giselle ^a   Sun, Baiming ^a   Zhang, Jinying ^b   Marbán, Eduardo ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cardiac regeneration; Cardiac stem cells; Myocardial infarction; Platelet gel

Indexed keywords

CARDIAC FUNCTIONS; CARDIAC REGENERATION; CARDIOMYOCYTES; EJECTION FRACTION; HISTOLOGICAL ANALYSIS; IN-VITRO; LEFT VENTRICULAR; MYOCARDIAL INFARCTION; PLATELET GEL; PLATELET GELS; RAT HEART; STEM CELL THERAPY; SYNGENEIC RATS; THERAPEUTIC EFFICACY; VEHICLE CONTROL;

BIOLOGICAL MATERIALS; BIOMATERIALS; CONTROL SYSTEM SYNTHESIS; ENDOTHELIAL CELLS; HEART; PLATELETS; RATS; STEM CELLS;

GELS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CARDIOSPHERE DERIVED CELL; CELL CULTURE; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CELLS; CONTROLLED STUDY; ENDOTHELIUM CELL; GEL; GEL TRANSPLANTATION; HEART; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; NONHUMAN; PLATELET GEL; PRIORITY JOURNAL; RAT; TRANSPLANTATION; VENOUS BLOOD;

ANIMALS; BLOOD PLATELETS; CELL SHAPE; CELLS, CULTURED; ENDOTHELIAL CELLS; GELS; HEART FUNCTION TESTS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; REGENERATION; STEM CELL TRANSPLANTATION;

RATTUS;

EID: 84862777056     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.12.040     Document Type: Article

References (25)

1. Ye Z., Zhou Y., Cai H., Tan W. Myocardial regeneration: roles of stem cells and hydrogels. Adv Drug Deliv Rev 2011, 63:688-697.
2. Christman K.L., Vardanian A.J., Fang Q., Sievers R.E., Fok H.H., Lee R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. JAm Coll Cardiol 2004, 44:654-660.
3. Cheng K., Malliaras K., Shen D., Tseliou E., Ionta V., Smith J., Galang G., et al. Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol 2012, 59:245-253.
4. Wang H., Zhou J., Liu Z., Wang C. Injectable cardiac tissue engineering for the treatment of myocardial infarction. JCell Mol Med 2010, 14:1044-1055.
5. Lee S.T., White A.J., Matsushita S., Malliaras K., Steenbergen C., Zhang Y., et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. JAm Coll Cardiol 2011, 57:455-465.
6. Li T.S., Cheng K., Lee S.T., Matsushita S., Davis D., Malliaras K., et al. Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells 2010, 28:2088-2098.
7. Cheng K., Li T.S., Malliaras K., Davis D.R., Zhang Y., Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106:1570-1581.
8. Davis D.R., Kizana E., Terrovitis J., Barth A.S., Zhang Y., Smith R.R., et al. Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. JMol Cell Cardiol 2010, 49:312-321.
9. Johnston P.V., Sasano T., Mills K., Evers R., Lee S.T., Smith R.R., et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120:1075-1083.
10. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., Messina E., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908.
11. Bryan N., Rhodes N.P., Hunt J.A. Derivation and performance of an entirely autologous injectable hydrogel delivery system for cell-based therapies. Biomaterials 2009, 30:180-188.
12. Terrovitis J., Lautamaki R., Bonios M., Fox J., Engles J.M., Yu J., et al. Noninvasive quantification and optimization of acute cell retention by invivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. JAm Coll Cardiol 2009, 54:1619-1626.
13. Kapoor N., Galang G., Marban E., Cho H.C. Transcriptional suppression of connexin43 by TBX18 undermines cell-cell electrical coupling in postnatal cardiomyocytes. JBiol Chem 2011, 286:14073-14079.
14. Chimenti I., Smith R.R., Li T.S., Gerstenblith G., Messina E., Giacomello A., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010, 106:971-980.
15. Stastna M., Chimenti I., Marban E., Van Eyk J.E. Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics 2010, 10:245-253.
16. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712.
17. Cheng K., Lai Y., Kisaalita W.S. Three-dimensional polymer scaffolds for high throughput cell-based assay systems. Biomaterials 2008, 29:2802-2812.
18. Shapira-Schweitzer K., Habib M., Gepstein L., Seliktar D. Aphotopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. JMol Cell Cardiol 2009, 46:213-224.
19. Lam C.K., Yoo T., Hiner B., Liu Z., Grutzendler J. Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization. Nature 2010, 465:478-482.
20. Frederick J.R., Fitzpatrick J.R., McCormick R.C., Harris D.A., Kim A.Y., Muenzer J.R., et al. Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis. Circulation 2010, 122:S107-S117.
21. Bearzi C., Rota M., Hosoda T., Tillmanns J., Nascimbene A., De Angelis A., et al. Human cardiac stem cells. Proc Natl Acad Sci U S A 2007, 104:14068-14073.
22. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
23. Li T.S., Cheng K., Malliaras K., Matsushita N., Sun B., Marban L., et al. Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair. Cardiovasc Res 2011, 89:157-165.
24. Li T.S., Marban E. Physiological levels of reactive oxygen species are required to maintain genomic stability in stem cells. Stem Cells 2010, 28:1178-1185.
25. Christman K.L., Lee R.J. Biomaterials for the treatment of myocardial infarction. JAm Coll Cardiol 2006, 48:907-913.